000 01462 a2200373 4500
005 20250515190602.0
264 0 _c20100203
008 201002s 0 0 eng d
022 _a1879-016X
024 7 _a10.1016/j.pharmthera.2009.09.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVillalón, Carlos M
245 0 0 _aThe role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs.
_h[electronic resource]
260 _bPharmacology & therapeutics
_cDec 2009
300 _a309-23 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnalgesics
_xtherapeutic use
650 0 4 _aAnimals
650 0 4 _aAzepines
_xtherapeutic use
650 0 4 _aBrain
_xblood supply
650 0 4 _aCalcitonin Gene-Related Peptide
_xphysiology
650 0 4 _aCalcitonin Gene-Related Peptide Receptor Antagonists
650 0 4 _aDipeptides
_xchemistry
650 0 4 _aDrug Delivery Systems
650 0 4 _aHumans
650 0 4 _aImidazoles
_xtherapeutic use
650 0 4 _aMigraine Disorders
_xdrug therapy
650 0 4 _aPiperazines
650 0 4 _aQuinazolines
_xchemistry
650 0 4 _aReceptors, Calcitonin Gene-Related Peptide
_xagonists
700 1 _aOlesen, Jes
773 0 _tPharmacology & therapeutics
_gvol. 124
_gno. 3
_gp. 309-23
856 4 0 _uhttps://doi.org/10.1016/j.pharmthera.2009.09.003
_zAvailable from publisher's website
999 _c19192130
_d19192130